Teams
Imagine's Offers
-
With temporal bones malformation
Isolated (SLC26A4)Genotype PhenotypeTargetsTherapeuticsClinical trialsSyndromic (FGF3)Genotype PhenotypeTargetsTherapeuticsClinical trialsWithout temporal bones malformation
Isolated (LHFPL5, OTOF, GJB2)Genotype PhenotypeTargetsTherapeuticsClinical trialsSyndromic - Usher syndromes 1, 2, and 3Genotype PhenotypeTargetsTherapeuticsClinical trialsSyndromic - TUBB4BGenotype PhenotypeTargetsTherapeuticsClinical trialsSyndromic - Heimler syndromeGenotype PhenotypeTargetsTherapeuticsClinical trialsAuditory neuropathies
Isolated (OTOF)Genotype PhenotypeTargetsTherapeuticsClinical trialsSyndromic (FDXR)Genotype PhenotypeTargetsTherapeuticsClinical trialsWith auditory nerve malformations (FGF3)Genotype PhenotypeTargetsTherapeuticsClinical trialsWith auditory nerve malformations (unknown genetic causes)Genotype PhenotypeTargetsTherapeuticsClinical trials
Contacts
-
Thibaut PERCHET
Business development manager
- thibaut.perchet@institutimagine.org
- +33 1 42 75 42 55